The final analysis of a multicenter randomized controlled trial of gemcitabine (G) alone versus gemcitabine and S-1 combination therapy (GS) in patients with unresectable advanced pancreatic cancer (PC): GEMSAP study.
H. Isayama
No relevant relationships to disclose
Y. Nakai
No relevant relationships to disclose
T. Sasaki
No relevant relationships to disclose
N. Sasahira
No relevant relationships to disclose
K. Hirano
No relevant relationships to disclose
T. Tsujino
No relevant relationships to disclose
M. Tada
No relevant relationships to disclose
M. Omata
No relevant relationships to disclose
K. Koike
No relevant relationships to disclose